Company
Headquarters: Taipei, Taiwan
CEO: Sophia Jan
TW$1.04 Billion
TWD as of Jan. 1, 2024
US$34.0 Million
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $207.62 B |
Danaher | $171.89 B |
Siemens Healthineers AG | $66.05 B |
DexCom, Inc. | $46.50 B |
IDEXX Laboratories, Inc. | $44.72 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
PharmiGene, Inc. develops, manufactures, and sells diagnostic tests worldwide. It primarily develops DNA genetic tests. The company was founded in 2005 and is headquartered in Taipei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Pharmigene, Inc. has the following listings and related stock indices.
Stock: TWSE: 7595 wb_incandescent